Erica L. Mayer, MD, MPH, is the Director of Clinical Research and an Institute Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute, as well as an Associate Professor in Medicine at Harvard Medical School.

Dr. Mayer received her medical degree from Harvard Medical School, completed a residency in Internal Medicine at Brigham and Women's Hospital, and a fellowship in Hematology/Oncology at Dana-Farber Cancer Institute. She obtained a Master's in Public Health from the Harvard School of Public Health. She was awarded the 2023 Canellos Award for Excellence in Clinical Investigation and Patient Care and is a Boston Magazine “Top Doctor.”

Dr. Mayer’s research focuses on the role of novel therapies in the treatment of breast cancer. She has been published in numerous peer-reviewed publications including Nature, Lancet Oncology, Journal of Clinical Oncology, and Annals of Oncology. She is the former Associate Director of the Dana-Farber Hematology/Oncology Fellowship Program, President of the Dana-Farber Medical Staff, and Co-Chair of the Dana-Farber Cancer Institute Clinical Faculty Council. Dr. Mayer is an active member of ASCO, ALLIANCE, as well as the Translational Breast Cancer Research Consortium.